Literature DB >> 15809419

Molecular recognition of an ADP-ribosylating Clostridium botulinum C3 exoenzyme by RalA GTPase.

Kenneth P Holbourn1, J Mark Sutton, Hazel R Evans, Clifford C Shone, K Ravi Acharya.   

Abstract

C3 exoenzymes (members of the ADP-ribosyltranferase family) are produced by Clostridium botulinum (C3bot1 and -2), Clostridium limosum (C3lim), Bacillus cereus (C3cer), and Staphylococcus aureus (C3stau1-3). These exoenzymes lack a translocation domain but are known to specifically inactivate Rho GTPases in host target cells. Here, we report the crystal structure of C3bot1 in complex with RalA (a GTPase of the Ras subfamily) and GDP at a resolution of 2.66 A. RalA is not ADP-ribosylated by C3 exoenzymes but inhibits ADP-ribosylation of RhoA by C3bot1, C3lim, and C3cer to different extents. The structure provides an insight into the molecular interactions between C3bot1 and RalA involving the catalytic ADP-ribosylating turn-turn (ARTT) loop from C3bot1 and helix alpha4 and strand beta6 (which are not part of the GDP-binding pocket) from RalA. The structure also suggests a molecular explanation for the different levels of C3-exoenzyme inhibition by RalA and why RhoA does not bind C3bot1 in this manner.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809419      PMCID: PMC556266          DOI: 10.1073/pnas.0501525102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  The Rho-ADP-ribosylating C3 exoenzyme from Clostridium botulinum and related C3-like transferases.

Authors:  C Wilde; K Aktories
Journal:  Toxicon       Date:  2001-11       Impact factor: 3.033

2.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

3.  An extensively modified version of MolScript that includes greatly enhanced coloring capabilities.

Authors:  R M Esnouf
Journal:  J Mol Graph Model       Date:  1997-04       Impact factor: 2.518

4.  Interaction of the Rho-ADP-ribosylating C3 exoenzyme with RalA.

Authors:  Christian Wilde; Holger Barth; Peter Sehr; Li Han; Martina Schmidt; Ingo Just; Klaus Aktories
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

Review 5.  Botulinum ADP-ribosyltransferase C3: a new tool to study low molecular weight GTP-binding proteins.

Authors:  K Aktories; A Hall
Journal:  Trends Pharmacol Sci       Date:  1989-10       Impact factor: 14.819

6.  Recognition of RhoA by Clostridium botulinum C3 exoenzyme.

Authors:  C Wilde; H Genth; K Aktories; I Just
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

7.  Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors.

Authors:  S Nakashima; K Morinaka; S Koyama; M Ikeda; M Kishida; K Okawa; A Iwamatsu; S Kishida; A Kikuchi
Journal:  EMBO J       Date:  1999-07-01       Impact factor: 11.598

8.  Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum.

Authors:  E J Rubin; D M Gill; P Boquet; M R Popoff
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

9.  Guanine nucleotide-dependent ADP-ribosylation of soluble rho catalyzed by Clostridium botulinum C3 ADP-ribosyltransferase. Isolation and characterization of a newly recognized form of rhoA.

Authors:  K C Williamson; L A Smith; J Moss; M Vaughan
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

10.  Structural basis of the interaction between RalA and Sec5, a subunit of the sec6/8 complex.

Authors:  Shuya Fukai; Hugo T Matern; Junutula R Jagath; Richard H Scheller; Axel T Brunger
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

View more
  9 in total

Review 1.  C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins.

Authors:  Martin Vogelsgesang; Alexander Pautsch; Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-12-05       Impact factor: 3.000

2.  Rho GTPase Recognition by C3 Exoenzyme Based on C3-RhoA Complex Structure.

Authors:  Akiyuki Toda; Toshiharu Tsurumura; Toru Yoshida; Yayoi Tsumori; Hideaki Tsuge
Journal:  J Biol Chem       Date:  2015-06-11       Impact factor: 5.157

Review 3.  Bacterial factors exploit eukaryotic Rho GTPase signaling cascades to promote invasion and proliferation within their host.

Authors:  Michel R Popoff
Journal:  Small GTPases       Date:  2014-05-08

4.  Crystal structure of the C3bot-RalA complex reveals a novel type of action of a bacterial exoenzyme.

Authors:  Alexander Pautsch; Martin Vogelsgesang; Jens Tränkle; Christian Herrmann; Klaus Aktories
Journal:  EMBO J       Date:  2005-09-22       Impact factor: 11.598

5.  Molecular Evolutionary Constraints that Determine the Avirulence State of Clostridium botulinum C2 Toxin.

Authors:  A Prisilla; R Prathiviraj; P Chellapandi
Journal:  J Mol Evol       Date:  2017-04-05       Impact factor: 2.395

6.  Discovery and characterization of small molecules that target the GTPase Ral.

Authors:  Chao Yan; Degang Liu; Liwei Li; Michael F Wempe; Sunny Guin; May Khanna; Jeremy Meier; Brenton Hoffman; Charles Owens; Christina L Wysoczynski; Matthew D Nitz; William E Knabe; Mansoor Ahmed; David L Brautigan; Bryce M Paschal; Martin A Schwartz; David N M Jones; David Ross; Samy O Meroueh; Dan Theodorescu
Journal:  Nature       Date:  2014-09-14       Impact factor: 49.962

7.  Chemical and functional aspects of posttranslational modification of proteins.

Authors:  D G Knorre; N V Kudryashova; T S Godovikova
Journal:  Acta Naturae       Date:  2009-10       Impact factor: 1.845

Review 8.  Clostridial C3 Toxins Target Monocytes/Macrophages and Modulate Their Functions.

Authors:  Holger Barth; Stephan Fischer; Amelie Möglich; Christina Förtsch
Journal:  Front Immunol       Date:  2015-06-30       Impact factor: 7.561

9.  De novo mutations in the GTP/GDP-binding region of RALA, a RAS-like small GTPase, cause intellectual disability and developmental delay.

Authors:  Susan M Hiatt; Matthew B Neu; Ryne C Ramaker; Andrew A Hardigan; Jeremy W Prokop; Miroslava Hancarova; Darina Prchalova; Marketa Havlovicova; Jan Prchal; Viktor Stranecky; Dwight K C Yim; Zöe Powis; Boris Keren; Caroline Nava; Cyril Mignot; Marlene Rio; Anya Revah-Politi; Parisa Hemati; Nicholas Stong; Alejandro D Iglesias; Sharon F Suchy; Rebecca Willaert; Ingrid M Wentzensen; Patricia G Wheeler; Lauren Brick; Mariya Kozenko; Anna C E Hurst; James W Wheless; Yves Lacassie; Richard M Myers; Gregory S Barsh; Zdenek Sedlacek; Gregory M Cooper
Journal:  PLoS Genet       Date:  2018-11-30       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.